Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04750629 · ClinicalTrials.gov registry record
Clinical Evaluation of a Point-of-Care (POC), COVID-19 Rapid Antigen Test (CoviDx™)
A clinical trial of Covid19 and SARS-CoV-2, sponsored by Lumos Diagnostics.
- Completed
- Registry status
- 140
- Enrollment target
- 2
- Study locations
NCT04750629 is a study of Covid19 and SARS-CoV-2 that has completed, run by Lumos Diagnostics. The registered enrollment target is 140 participants, below the 2,701-participant average among 94 other Covid19 trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT04750629, a study of Covid19 and SARS-CoV-2, has completed, sponsored by Lumos Diagnostics.
- COMPLETED
- Registry status
- 140 participants
- Enrollment target
- 2
- Study locations
Study Summary
Prospective study that will evaluate the clinical agreement of the CoviDx™ Rapid Antigen test compared to SARS-CoV-2 RT-PCR.
Conditions Studied
Interventions
- DEVICE POC CoviDx™ Rapid Antigen Test
Study Locations (2)
Florida
- Doral Medical Research - Hialeah
- Comprehensive Clinical Research - West Palm Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2021-02-08 |
| Est. Completion | 2021-05-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04750629
The ClinicalTrials.gov registry entry for NCT04750629 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,701-participant average among 94 other Covid19 trials with a reported enrollment target (95% lower). The listed sponsor is Lumos Diagnostics, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Covid19 appearing as the primary indexed condition, and to 1 intervention - of which POC CoviDx™ Rapid Antigen Test is the first listed.
NCT04750629 reports 2 study locations spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04750629 about?
NCT04750629 is a clinical study titled "Clinical Evaluation of a Point-of-Care (POC), COVID-19 Rapid Antigen Test (CoviDx™)". Prospective study that will evaluate the clinical agreement of the CoviDx™ Rapid Antigen test compared to SARS-CoV-2 RT-PCR.
What is the current status of trial NCT04750629?
This trial is currently completed. The enrollment target is 140 participants. The study started on 2021-02-08. Estimated completion is 2021-05-14.
What conditions does trial NCT04750629 study?
This clinical trial studies the following conditions: Covid19, SARS-CoV-2.
What interventions are being tested in trial NCT04750629?
The interventions under investigation include: POC CoviDx™ Rapid Antigen Test (DEVICE).
Who is sponsoring clinical trial NCT04750629?
This trial is sponsored by Lumos Diagnostics, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04750629 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Immune Activation in COVID-19
RECRUITING · Phase 2
-
Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
RECRUITING · Phase 2
-
COVID-19 Vaccines International Pregnancy Exposure Registry
RECRUITING
-
COVID-19 Survivorship Registry
RECRUITING
-
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
RECRUITING · Phase 3
-
Conversations You Want About Corona Virus Disease (COVID-19)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.